• AS1842856 Foxo1 Inhibitor Workflow

  2026-09-11

  Build cleaner metabolic assays by separating Foxo1 activity from Foxo1 abundance with AS1842856. This workflow connects hepatic gluconeogenesis and autophagy research with a carefully bounded, hypothesis-generating approach to PI3K-Akt-Foxo1 signaling in mesenchymal stem cells.

• Baricitinib: From Spatial Signals to JAK Assays

  2026-09-10

  Baricitinib and LY3009104 provide a practical pharmacological bridge between spatial proteomics findings in primary sclerosing cholangitis and functional JAK1/2 assays. This article explains how to translate PD-L1–IL-6 neighborhood signals into interpretable STAT3, IL-6, and IL-23 experiments without overstating what the evidence proves.

• BipD Hijacks Mitophagy Through CUL3 Ubiquitination

  2026-09-10

  The reference study shows that Burkholderia pseudomallei uses its type III secretion system protein BipD to redirect host mitochondrial quality control. BipD engages KLHL9/KLHL13–CUL3 ubiquitin ligase activity, promotes K63-linked ubiquitination of IMMT at K211, and activates mitophagy that lowers mitochondrial reactive oxygen species and supports intracellular bacterial survival.

• Reactive Oxygen Species Assay Kit: DCFH-DA Guide

  2026-09-09

  The Reactive Oxygen Species Assay Kit (K2065) uses the DCFH-DA fluorescent probe to support comparative cellular ROS level quantification in live cells. Its Rosup positive control and defined storage specifications help researchers evaluate oxidative stress workflows alongside disease-model readouts.

• MK-4827 and the Next Phase of PARP Research

  2026-09-09

  A translational framework for using MK-4827 (Niraparib) to study BRCA-associated vulnerability, platinum-induced PARP inhibitor resistance, DNA damage repair inhibition, and rational chemo- and radio-potentiation.

• Luminescent ATP Cell Viability Assay Kit I

  2026-09-08

  Learn how Luminescent ATP Cell Viability Assay Kit I (SKU K2041) supports sensitive, rapid cell viability measurement in proliferation and cytotoxicity workflows. This scenario-based guide covers assay principles, protocol optimization, interpretation, and practical product selection.

• NF449 Maps P2 Receptor Roles in Platelet Thrombosis

  2026-09-07

  The reference study established NF449 as a comparatively selective antagonist of platelet P2X1 receptors and used complementary human platelet and mouse thrombosis models to define receptor-specific functions. Its results connect P2X1 blockade with reduced platelet activation and thrombus formation while showing that stronger, broader P2-receptor inhibition produces greater antithrombotic activity.

• NLRP3 S-Acylation Gates Golgi Access

  2026-09-07

  The reference study identifies S-acylation of NLRP3 at conserved Cys-130 as a dynamic membrane-targeting mechanism that controls Golgi recruitment. Its findings refine the electrostatic model of NLRP3 localization by showing how nigericin-induced Golgi disruption can reduce de-acylation and immobilize NLRP3 at the Golgi.

• From Reporter Signal to Translational mRNA Strategy

  2026-09-05

  A mechanistic and strategic guide to using EZ Cap™ EGFP mRNA (5-moUTP) as a benchmark for mRNA delivery, translation, innate immune control, and translational decision-making.

• ARCA Cy5 EGFP mRNA (5-moUTP): Assay Guide

  2026-09-05

  ARCA Cy5 EGFP mRNA (5-moUTP) enables direct comparison of cellular delivery, intracellular localization, and productive translation. This guide shows how 5-methoxyuridine modified mRNA can function as a mechanistic benchmark for evaluating emerging mammalian-cell delivery systems.

• Spatial Proteomics Links PD-L1 and IL-6 in PSC

  2026-09-04

  Orlandi and colleagues integrate spatial proteomics with cell-cell cross-talk analysis to examine how PD-L1 and IL-6 signaling converge at the epithelial-immune interface in human primary sclerosing cholangitis. The study provides a spatially resolved framework for interpreting PSC inflammation and for designing follow-up perturbation experiments, while its observational design means that pathway causality remains to be tested.

• Biotin-16-UTP for RNA Capture Workflows

  2026-09-04

  Biotin-16-UTP adds an affinity handle to in vitro-transcribed RNA, enabling practical workflows for RNA detection and purification, interaction mapping, and probe development. This guide connects controllable biotin-labeled RNA synthesis with the native-protein tracking concepts introduced by a recent biosensor study.

• Chlorpromazine HCl in Endocytosis Assay Design

  2026-09-03

  Chlorpromazine HCl is more than a dopamine receptor antagonist: it can serve as a mechanistic perturbation in carefully controlled neuropharmacology and nanoparticle-uptake assays. This guide explains how to interpret its effects without confusing receptor pharmacology, membrane trafficking, and electrical-stimulation biology.

• Carbapenemase Gene Transmission in CREC, Guangdong

  2026-09-02

  Chen et al. integrated gene localization, antimicrobial susceptibility testing, conjugation assays, mobile genetic element analysis, and ERIC-PCR genotyping to investigate carbapenem-resistant Enterobacter cloacae across eight Guangdong teaching hospitals. The study identifies plasmid-associated blaNDM-1 and efficient horizontal transfer as central drivers of resistance dissemination, while also showing substantial strain diversity and cross-hospital clustering.

• ISRIB (trans-isomer): From ISR to Memory Retention

  2026-09-02

  ISRIB (trans-isomer) is a mechanistically distinctive PERK inhibitor for connecting eIF2α signaling with memory retention. This article translates recent epilepsy-related findings into practical ER stress research, apoptosis assay, and cognitive-memory study decisions.

8643 records 1/577 page Next 12345 下5页 Last page